NCT02453035View on ClinicalTrials.gov

DESolve® X-Pand Global Post Market Registry

TerminatedOBSERVATIONAL
Enrollment

154

Participants

Timeline

Start Date

May 13, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

April 30, 2017

Conditions
Coronary Artery Stenosis
Interventions
DEVICE

PTCA - Desolve Scaffold

Percutaneous Coronary Artery Intervention with a DESolve bioresorbable coronary scaffold

Trial Locations (5)

3430

St. Antonius Ziekenhuis, Nieuwegein

35392

Universitätsklinikum Giessen, Giessen

54292

Krankenhaus der Barmherzigen Brüder, Trier

61231

Kerckhoff-Klinik, Bad Nauheim

65428

GPR Klinikum Rüsselsheim, Rüsselsheim am Main

Sponsors
All Listed Sponsors
collaborator

European Cardiovascular Research Center

NETWORK

lead

Elixir Medical Corporation

INDUSTRY

NCT02453035 - DESolve® X-Pand Global Post Market Registry | Biotech Hunter | Biotech Hunter